Partnership Forum: Participants discussed how digital therapeutics with web and designed based applications are emerging as a means to treat conditions by engaging people to improve health and wellness.
Oncology Partnership Forum - Part I
The AMCP Partnership Forum, Driving Value and Outcomes in Oncology, which took place on November 15-16, 2016, focused on the need to drive better value and outcomes in oncology for patients, providers, payers and delivery networks. Attendees discussed ideas and concepts to help sort through a wave of new oncology products coming to market each year. The event drew roughly 40 thought leaders from health plans, integrated delivery systems, PBMs, clinical practice, the biopharmaceutical companies, and laboratory companies. Also participating were representatives from the American Society of Clinical Oncology, the National Comprehensive Cancer Network, and the Hematology/Oncology Pharmacy Association.
The Forum was moderated by Susan Winckler, Chief Risk Management Officer, Leavitt Partners and Former Chief of Staff of the US Food and Drug Administration.
The Forum was held in partnership with Abbvie, Amgen, Bristol-Myers Squibb, Celgene, Foundation Medicine, Ion Solutions, Janssen Oncology, Lilly & Co., the National Pharmaceutical Council, Novartis, Pharmaceutical Research and Manufacturers of America, Sanofi, Takeda Oncology and Xcenda.
Additional Materials:
Related
This advisory group was active from March 2021-June 2022.
This advisory group was active from April 2021-March 2022.
Featured News & Resources
See Full CalendarNews & Resources by Topic
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
